What Causes Biliary Atresia? Unique Aspects of the Neonatal Immune System Provide Clues to Disease Pathogenesis

por Mack, Cara L.
Publicado 2015

HLA Associations in pediatric autoimmune liver diseases: Current state and future research initiatives

por Mack, Cara L.
Publicado 2022

B Cell Deficient Mice Are Protected from Biliary Obstruction in the Rotavirus-Induced Mouse Model of Biliary Atresia

por Feldman, Amy G., Tucker, Rebecca M., Fenner, Erika K., Pelanda, Roberta, Mack, Cara L.
Publicado 2013

High Dose IgG Therapy Mitigates Bile Duct Targeted Inflammation and Obstruction in a Mouse Model of Biliary Atresia

por Fenner, Erika K., Boguniewicz, Juri, Tucker, Rebecca M., Sokol, Ronald J., Mack, Cara L.
Publicado 2014

Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis

por Harrington, Claire, Krishnan, Swathi, Mack, Cara L., Cravedi, Paolo, Assis, David N., Levitsky, Josh
Publicado 2022

Lack of HLA predominance and HLA shared epitopes in biliary Atresia

por Mack, Cara L, Anderson, Kirsten M, Aubrey, Michael T, Rosenthal, Philip, Sokol, Ronald J, Freed, Brian M
Publicado 2013

The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan–aspartate aminotransferase to predict severity of liver disease...

por Chaidez, Alexander, Pan, Zhaoxing, Sundaram, Shikha S., Boster, Julia, Lovell, Mark, Sokol, Ronald J., Mack, Cara L.
Publicado 2022

431 Galectin-3 as a Biomarker and Potential Therapeutic Target in Biliary Atresia

por Yoeli, Dor, Luo, Yuhuan, Chaidez, Alexander, Wang, Zhaohui, Adams, Megan A., Huang, Christene A., Mack, Cara L., Navarro-Alvarez, Nalu
Publicado 2022

Cytomegalovirus in biliary atresia is associated with increased pretransplant death, but not decreased native liver survival

por Kemme, Sarah, Canniff, Jennifer D., Feldman, Amy G., Garth, Krystle M., Li, Shaobing, Pan, Zhaoxing, Sokol, Ronald J., Weinberg, Adriana, Mack, Cara L.
Publicado 2023

Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy

por Kim, Sehee, Moore, Jeffrey, Alonso, Estella, Bednarek, Joseph, Bezerra, Jorge A., Goodhue, Catherine, Karpen, Saul J., Loomes, Kathleen M., Magee, John C., Ng, Vicky L., Sherker, Averell H., Smith, Caroline, Spino, Cathie, Venkat, Veena, Wang, Kasper, Sokol, Ronald J., Mack, Cara L.
Publicado 2019

Placebo‐Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome

por Shneider, Benjamin L., Spino, Cathie, Kamath, Binita M., Magee, John C., Bass, Lee M., Setchell, Kenneth D., Miethke, Alexander, Molleston, Jean P., Mack, Cara L., Squires, Robert H., Murray, Karen F., Loomes, Kathleen M., Rosenthal, Philip, Karpen, Saul J., Leung, Daniel H., Guthery, Stephen L., Thomas, Danny, Sherker, Averell H., Sokol, Ronald J.
Publicado 2018

Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome

por Kamath, Binita M., Spino, Cathie, McLain, Richard, Magee, John C., Fredericks, Emily M., Setchell, Kenneth D., Miethke, Alexander, Molleston, Jean P., Mack, Cara L., Squires, Robert H., Alonso, Estella M., Murray, Karen F., Loomes, Kathleen M., Kyle Jensen, M., Karpen, Saul J., Rosenthal, Philip, Thomas, Danny, Sokol, Ronald J., Shneider, Benjamin L.
Publicado 2020

Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age

por Venkat, Veena, Ng, Vicky L., Magee, John C., Ye, Wen, Hawthorne, Kieran, Harpavat, Sanjiv, Molleston, Jean P., Murray, Karen F., Wang, Kasper S., Soufi, Nisreen, Bass, Lee M., Alonso, Estella M., Bezerra, Jorge A., Jensen, M. Kyle, Kamath, Binita M., Loomes, Kathleen M., Mack, Cara L., Rosenthal, Philip, Shneider, Benjamin L., Squires, Robert H., Sokol, Ronald J., Karpen, Saul J.
Publicado 2020

Outcomes of Childhood Cholestasis in Alagille Syndrome: Results of a Multicenter Observational Study

por Kamath, Binita M., Ye, Wen, Goodrich, Nathan P., Loomes, Kathleen M., Romero, Rene, Heubi, James E., Leung, Daniel H., Spinner, Nancy B., Piccoli, David A., Alonso, Estella M., Guthery, Stephen L., Karpen, Saul J., Mack, Cara L., Molleston, Jean P., Murray, Karen F., Rosenthal, Philip, Squires, James E., Teckman, Jeffrey, Wang, Kasper S., Thompson, Richard, Magee, John C., Sokol, Ronald J.
Publicado 2020

Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis

por Thompson, Richard J., Artan, Reha, Baumann, Ulrich, Calvo, Pier Luigi, Czubkowski, Piotr, Dalgic, Buket, D’Antiga, Lorenzo, Di Giorgio, Angelo, Durmaz, Özlem, Gonzalès, Emmanuel, Grammatikopoulos, Tassos, Gupte, Girish, Hardikar, Winita, Houwen, Roderick H.J., Kamath, Binita M., Karpen, Saul J., Lacaille, Florence, Lachaux, Alain, Lainka, Elke, Loomes, Kathleen M., Mack, Cara L., Mattsson, Jan P., McKiernan, Patrick, Ni, Quanhong, Özen, Hasan, Rajwal, Sanjay R., Roquelaure, Bertrand, Shteyer, Eyal, Sokal, Etienne, Sokol, Ronald J., Soufi, Nisreen, Sturm, Ekkehard, Tessier, Mary Elizabeth, van der Woerd, Wendy L., Verkade, Henkjan J., Vittorio, Jennifer M., Wallefors, Terese, Warholic, Natalie, Yu, Qifeng, Horn, Patrick, Kjems, Lise
Publicado 2023